IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

OUP Management Co., LLC

Q4 2021 Holdings

Filed 2022-02-03 | 16 holdings | $221.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
ionQ, Inc.(IONQ)Common Stock46222L108$69.3K4,147,08131.2%
Cyteir Therapeutics, Inc.Common Stock23284P103$28.1K2,474,57212.7%
Centessa Pharmaceuticals plc(CNTA)Sponsored ADS152309100$26.4K2,341,89111.9%
PMV Pharmaceuticals, Inc.(PMVP)Common Stock69353Y103$22.9K989,23210.3%
Dice Therapeutics Inc.Common Stock23345J104$13.6K536,6936.1%
Landos Biopharma, Inc.Common Stock515069102$8.8K1,827,4784.0%
eFFECTOR Therapeutics, Inc.Common Stock28202V108$8.5K1,025,6973.8%
Precision BioSciences, Inc.Common Stock74019P108$8.3K1,123,9133.7%
Evolv Technologies Holdings, Inc.(EVLV)Common Stock30049H102$8.1K1,820,8663.7%
Aerovate Therapeutics Inc.Common Stock008064107$7.1K603,7623.2%
Graphite Bio(GRPH)Common Stock38870X104$5.1K406,3082.3%
Sera Prognostics, Inc.(SERA)Common Stock81749D107$4.4K641,3612.0%
Vor Biopharma Inc.Common Stock929033108$4.4K374,7142.0%
Spero Therapeutics, Inc.(SPRO)Common Stock84833T103$4.0K249,0701.8%
Selecta Biosciences, Inc.(SELBUSD)Common Stock816212104$2.8K862,5431.3%
Homology Medicines, Inc.Common Stock438083107$23364,0000.1%